JASON GARDNER

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for Jason Gardner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JASON GARDNER:

Company Role Class Num Shares Value Price $ Report Date Ownership
Magenta Therapeutics, Inc. Title: President and Chief Executive Officer, Director Common Stock 359,092 $4,309,104 $12.00 30 Nov 2022 By P.S. Gardner Irrevocable Trust
Magenta Therapeutics, Inc. Title: President and Chief Executive Officer, Director Common Stock 292,990 $3,515,880 $12.00 30 Nov 2022 By J.P. Gardner Irrevocable Trust
Magenta Therapeutics, Inc. Title: President and Chief Executive Officer, Director Common Stock 292,872 $3,514,464 $12.00 30 Nov 2022 Direct

Insider Reports Filed by JASON GARDNER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MGTA Magenta Therapeutics, Inc. 30 Nov 2022 1 $2,820 4 Title: President and Chief Executive Officer, Director 02 Dec 2022, 15:23
MGTA Magenta Therapeutics, Inc. 01 Aug 2022 1 $0 4 Title: President and Chief Executive Officer Exhibit 24.1: Power of Attorney, Director 01 Aug 2022, 21:13
MGTA Magenta Therapeutics, Inc. 31 May 2022 1 $2,970 4 Title: President and Chief Executive Officer, Director 06 Jun 2022, 16:05
MGTA Magenta Therapeutics, Inc. 17 May 2022 1 $0 4 Title: President and Chief Executive Officer, Director 19 May 2022, 16:23
MGTA Magenta Therapeutics, Inc. 15 Feb 2022 1 $0 4 Title: President and Chief Executive Officer, Director 17 Feb 2022, 16:31
MGTA Magenta Therapeutics, Inc. 16 Sep 2021 1 $96,508 4 President and Chief Executive Officer 20 Sep 2021, 17:00
MGTA Magenta Therapeutics, Inc. 14 Sep 2021 1 $0 4 President and Chief Executive Officer, Director 16 Sep 2021, 19:40
MGTA Magenta Therapeutics, Inc. 02 Aug 2021 1 $0 4 Title: President and Chief Executive Officer, Director 03 Aug 2021, 16:33